Using the same registries which later incorporated Ph and/or BCR::ABL1, the second study examined 4,287 first-degree relatives of 88 CML patients diagnosed between 2002 and 2013 and compared them with 20,930 first-degree relatives of matched controls [60]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.